Evidence map›Paper›PMID 35796848›Full record

ArticleClinical rheumatology2022

Revisiting reactive arthritis during the COVID-19 pandemic.

Dana Bekaryssova, Marlen Yessirkepov, Olena Zimba, Armen Yuri Gasparyan, Sakir Ahmed

Open access · bronzeAbstract readLetter
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Dana BekaryssovaDepartment of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.ORCID http://orcid.org/0000-0002-9651-7295
Marlen YessirkepovDepartment of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.ORCID http://orcid.org/0000-0003-2511-6918
Olena ZimbaDepartment of Internal Medicine #2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.ORCID http://orcid.org/0000-0002-4188-8486
Armen Yuri GasparyanDepartments of Rheumatology and Research and Development, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Russells Hall Hospital, Dudley, West Midlands, UK.ORCID http://orcid.org/0000-0001-8749-6018
Sakir AhmedDepartment of Clinical Immunology and Rheumatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, 751024, India. sakir005@gmail.com.ORCID http://orcid.org/0000-0003-4631-311X
South Kazakhstan Medical Academy · KZDanylo Halytsky Lviv National Medical University · UAInstitute of Medical Sciences · INRussells Hall Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Arthritis, ReactiveCOVID-19HumansPandemicsSARS-CoV-2

Identifiers

PMID35796848
PMCPMC9261121
OpenAlexW4284889926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.